Pandorum Technologies – startup that constructs regenerative medicine for patients of Covid-19 and chronic ailments

Pandorum Technologies is a Bangalore based biotechnology startup. Its focus is on tissue engineering and regenerative medicine. Pandorum Technologies amalgamates clinical competencies, life science, and engineering to design and manufacture three dimensional functional human tissues; intended for therapeutics and medical research.

The multi-disciplinary team of Pandorum Technologies, addresses the most important challenges of healthcare by developing and disseminating high-end healthcare products. The team has been using technological and scientific competencies to elevate the quality and duration of people’s lives. Regenerative medicine, drug screening, tissue engineering, biomaterials, organoids, liver, cornea and 3D bioprinting are the focus areas of the startup. Pandorum Technologies uses translational principles of engineering and biology to design therapeutic products that alleviate sufferings of patients of liver diseases, lung related disorders, and corneal dystrophies.

Healthcare Solutions of Pandorum Technologies 

Pandorum builds 3D functional tissues through a combination of cells, cell modulators, and gels using 3D printing, self-assembly, and other fabrication methods to construct desired tissue. As per Pandorum’s website, its proprietary technology platform is designed to develop the following functional human tissues enabling therapeutic and medical research applications: 

“Bio-engineered Cornea - biomimetic bioengineered support for restoring vision. Currently, Pandorum is performing pre-clinical animal trials and aiming towards human clinical trials. 

Liver - Pandorum’s 3D organoids containing multi-lineage cell types recapitulate the native microenvironment with parenchymal hepatocytes co-cultured with kupffer cells, hepatic stellate cells and liver endothelial cells. These organoids are induced to recapitulate the complex disease phenotype including steatosis, inflammation and fibrosis involving multiple cell-cell cross talks. 

Lung Regeneration - Since the outbreak of COVID19, Pandorum is expanding its reach by further developing the exosome platform, particularly for the post COVID19 trauma. Pandorum Technologies uses exosome therapy which is a cell-free therapy. With the manifestation of the defined set of cargo, healing of lung tissue in the COVID19 patients could be made easier. In this therapy, exosomes packed with immuno-modulatory, anti-fibrotic factors could alleviate the pain, inflammation, and pulmonary fibrosis which will lead to the tissue repair.” 

Tuhin Bhowmick and Arun Chandru are the co-founders of the organization. They have featured in Forbes Asia '30 under 30' – 2016, and have won many awards and accolades like BioExcellence Award in Biopharma and Healthcare – 2016, Top Innovator Award – 2017, First Place in 2019 Entrepreneurship World Cup (India), Top 50 Disruptive Startups of India award – 2019. Pandorum Technologies was launched in the year 2011.

Tags : #pandorumtechnologies #regenerativemedicine #biotechnologystartup #tissueengineering #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Exploring the Link Between Covid-19 Vaccination and Sudden Cardiac Arrests: ICMR StudyNovember 22, 2023
Powering the Future: China's Biodegradable Wireless System for Bioelectronic InnovationNovember 22, 2023
IMS BHU Pioneers Advanced Cardiac Care: Unveiling Cutting-Edge Technologies for Precise DiagnosisNovember 18, 2023
Inito's $6 Million Boost: Transforming Women's Health with AI-Backed Fertility MonitoringNovember 18, 2023
Madras High Court Advocates for Equality: PG Medical Students to Receive Incentive Marks for COVID-19 DutyNovember 18, 2023
Next-Gen Healthcare: CarePods and AI Redefine the Patient ExperienceNovember 17, 2023
Air Quality Crisis: Alarming Rise in Premature Births Linked to Air Quality in Begusarai, BiharNovember 17, 2023
Limerick Contest-2023: A Celebration of Wit and PoetryNovember 17, 2023
IIIT-Hyderabad among top 100 institutions for 5G Use Case LabNovember 17, 2023
Powerful, motivating and inspiring talks marked TEDx Hyderabad Women 2023 which was held with the theme "Two Steps ForwardNovember 17, 2023
Speaking the Diagnosis: How AI in Voice Analysis Is Revolutionizing Diabetes DetectionNovember 17, 2023
FDA Approves Zepbound: A New Medication for Weight Loss by Eli LillyNovember 17, 2023
CoverSelf Raises $8.2 Million in Seed Funding to Revolutionize Healthcare Claims with Innovative Fintech PlatformNovember 16, 2023
From Miracle to Medic: The Extraordinary Journey of India's First Paediatric Liver Transplant RecipientNovember 16, 2023
Combatting Chikungunya: Valneva's Chikungunya Vaccine Cleared by USFDA, Eyes India LaunchNovember 16, 2023
Global Corporate Summit 2023 with the theme Unlocking Opportunities in a Dynamic World heldNovember 16, 2023
2nd IHub-Data Mobility Summit heldNovember 16, 2023
Revolutionary AI-powered technology detects multiple abdominal pathologies simultaneouslyNovember 16, 2023
1 Out of 3 Stroke Patients Suffer Long-Term Health Complications, Says NeurologistNovember 16, 2023
Amrita Hospital, Kochi, Launches App for People with Swallowing DifficultiesNovember 15, 2023